中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2015年
9期
1254-1258
,共5页
王爱华%管世鹤%杨凯%张浩%孙蓓蓓%潘颖%沈继龙
王愛華%管世鶴%楊凱%張浩%孫蓓蓓%潘穎%瀋繼龍
왕애화%관세학%양개%장호%손배배%반영%침계룡
肝炎病毒%乙型%质粒%PKR蛋白%抗原%复制%细胞
肝炎病毒%乙型%質粒%PKR蛋白%抗原%複製%細胞
간염병독%을형%질립%PKR단백%항원%복제%세포
hepatitis B virus%plasmid%PKR protein%antigen%complication%cells
目的:构建表达双链 RNA 依赖性蛋白激酶(PKR)融合绿色增强荧光蛋白(pEGFP-PKR)真核表达质粒,并进一步研究 PKR 蛋白在体外抗乙型肝炎病毒(HBV)活性。方法以 pEGFP-N1为空载体,运用分子克隆技术构建重组质粒pEGFP-PKR,通过双酶切和直接测序两种方法验证重组质粒pEGFP-PKR 是否构建成功。以能分泌完整 HBV 病毒颗粒子的肝胚瘤细胞株 HepG2.2.15细胞为细胞模型,采用重组质粒转染方式处理 HepG2.2.15细胞,运用荧光显微镜观察融合蛋白 pEGFP-PKR 在细胞内的表达,以电化学发光方法和实时荧光定量 PCR 技术分析细胞上清 HBV 抗原表达和细胞病毒复制水平。结果酶切鉴定和序列分析证实成功构建重组质粒 pEGFP-PKR,转染 HepG2.2.15细胞后在荧光显微镜下可见融合蛋白 pEGFP-PKR 表达,同时细胞分泌的HBV 抗原与空载体组相比较明显下降(P <0.05),而细胞外HBV 复制水平未见明显变化。结论在体外肝细胞模型中,PKR 蛋白具有一定的抗 HBV 活性作用。
目的:構建錶達雙鏈 RNA 依賴性蛋白激酶(PKR)融閤綠色增彊熒光蛋白(pEGFP-PKR)真覈錶達質粒,併進一步研究 PKR 蛋白在體外抗乙型肝炎病毒(HBV)活性。方法以 pEGFP-N1為空載體,運用分子剋隆技術構建重組質粒pEGFP-PKR,通過雙酶切和直接測序兩種方法驗證重組質粒pEGFP-PKR 是否構建成功。以能分泌完整 HBV 病毒顆粒子的肝胚瘤細胞株 HepG2.2.15細胞為細胞模型,採用重組質粒轉染方式處理 HepG2.2.15細胞,運用熒光顯微鏡觀察融閤蛋白 pEGFP-PKR 在細胞內的錶達,以電化學髮光方法和實時熒光定量 PCR 技術分析細胞上清 HBV 抗原錶達和細胞病毒複製水平。結果酶切鑒定和序列分析證實成功構建重組質粒 pEGFP-PKR,轉染 HepG2.2.15細胞後在熒光顯微鏡下可見融閤蛋白 pEGFP-PKR 錶達,同時細胞分泌的HBV 抗原與空載體組相比較明顯下降(P <0.05),而細胞外HBV 複製水平未見明顯變化。結論在體外肝細胞模型中,PKR 蛋白具有一定的抗 HBV 活性作用。
목적:구건표체쌍련 RNA 의뢰성단백격매(PKR)융합록색증강형광단백(pEGFP-PKR)진핵표체질립,병진일보연구 PKR 단백재체외항을형간염병독(HBV)활성。방법이 pEGFP-N1위공재체,운용분자극륭기술구건중조질립pEGFP-PKR,통과쌍매절화직접측서량충방법험증중조질립pEGFP-PKR 시부구건성공。이능분비완정 HBV 병독과입자적간배류세포주 HepG2.2.15세포위세포모형,채용중조질립전염방식처리 HepG2.2.15세포,운용형광현미경관찰융합단백 pEGFP-PKR 재세포내적표체,이전화학발광방법화실시형광정량 PCR 기술분석세포상청 HBV 항원표체화세포병독복제수평。결과매절감정화서렬분석증실성공구건중조질립 pEGFP-PKR,전염 HepG2.2.15세포후재형광현미경하가견융합단백 pEGFP-PKR 표체,동시세포분비적HBV 항원여공재체조상비교명현하강(P <0.05),이세포외HBV 복제수평미견명현변화。결론재체외간세포모형중,PKR 단백구유일정적항 HBV 활성작용。
Aim To construct and express the eukary-otic expression vector of double-stranded RNA-depend-ent protein kinase (PKR)fusion green fluorescent and analyse its antiviral activity of HBV in vitro.Methods The PKR gene was cloned into an empty expression vector pEGFP-N1 using molecular clone technology. After being confirmed by restriction enzyme digestion and sequencing methods,the recombinant plasmid was named as pEGFP-PKR that was subsequently transfect-ed into HepG2.2.15 cells using LipofectamineTM2000. The expression level of PKR in HepG2.2.15 cells was confirmed by using fluorescent microscopy. Mean-while,HBV DNA and HBsAg/HBeAg were detected by real-time PCR and electrochemiluminescence meth-od,respectively.Results Both restriction enyme di-gestion and sequencing assays showed that the recombi-nant vector pEGFP-PKR was successfully constructed in our study.Fluorescent microscopy observation indi-cated that the fusion protein pEGFP-PKR expressed ef-ficiently in HepG2.2.15 cells.Moreover,compared with the empty vector group,the expression of HBV antigen in supernatants was significantly decreased (P<0.05 ).However,the extracellular HBV DNA ex-pression was not inhibited significantly.Conclusion In vitro,PKR proteion has certain antiviral activity of HBV.